Charles P. Hudson
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Asthma and respiratory diseases, Antifungal resistance and susceptibility
Most-Cited Works
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → Cutaneous Angiosarcoma in a Site of Healed Herpes Zoster(1984)53 cited
- → Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis(2003)44 cited
- Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.(2011)
- → Cutaneous Leukocytoclastic Vasculitis With Hyperglobulinemia and Splenomegaly(1984)18 cited
- A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.(2011)
- → The tetracycline-oral contraceptive controversy(1982)12 cited
- An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis.(2011)
- → Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis(2003)6 cited
- Systemic blastomycosis treated with ketoconazole.(1984)